Method of treating fibrotic disease

Disclosed herein are methods of treating fibrotic disorders by administering compounds selective for CAPN1, CAPN2, and/or CAPN9 such that side effects, off pathway interactions, and/or toxicities are minimized Such methods may, for example, minimize unintended effects of therapeutic compounds by pro...

Full description

Saved in:
Bibliographic Details
Main Authors IBRAHIM Prabha, RAJAGOPALAN P.T. Ravi, BUCKMAN Brad Owen
Format Patent
LanguageEnglish
Hebrew
Published 30.11.2020
Online AccessGet full text

Cover

More Information
Summary:Disclosed herein are methods of treating fibrotic disorders by administering compounds selective for CAPN1, CAPN2, and/or CAPN9 such that side effects, off pathway interactions, and/or toxicities are minimized Such methods may, for example, minimize unintended effects of therapeutic compounds by providing dosing and dosage forms that minimize the level of unbound drug within the relevant tissues of a patient undergoing treatment.
Bibliography:Application Number: IL20200277500